Complex Diabetic Cases: A Closer Look at Clinical Trials

Complex Diabetic Cases A Closer Look at Clinical Trials
Media formats available:
Details
Presenters
  • Overview

    This case discussion between Allen C. Ho, MD, FACS, and Jennifer I. Lim, MD, focuses on more challenging cases of diabetic eye disease. Drs. Ho and Lim discuss the impact of pivotal trials and their applicability to patients in the real-world, which can be unpredictable and include barriers to care.

    Supported by an independent medical education grant from Regeneron Pharmaceuticals.

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Discuss the benefits of consistent anti-VEGF treatment.
    • Execute patient education plans on the importance of frequent DME treatment to improve treatment and exam compliance.
    • Apply best practices and strategies in a cross-disciplinary approach to diabetes management to better manage patients.
    • Accreditation

      This educational activity is provided by Evolve Medical Education LLC (Evolve).

      Accreditation Statement
      Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
      Evolve designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™.
      Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    • Participation Method

      In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

    • Faculty and Disclosures

      Allen C. Ho, MD, FACS

      Allen C. Ho, MD, FACS

      Wills Eye Hospital
      Attending Surgeon 
      Director of Retina Research
      Professor of Ophthalmology
      Thomas Jefferson University
      Mid Atlantic Retina
      President, The Retina Society


      Jennifer I. Lim, MD

      Jennifer I. Lim, MD

      Marion H. Schenk Chair in Ophthalmology
      Professor of Ophthalmology
      Vice-Chair for Diversity & Inclusion
      Director of the Retina Service
      University of Illinois at Chicago
      Chicago, IL


      DISCLOSURE POLICY
      It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.

      The following faculty/staff members have the following financial relationships with commercial interests:

      Allen C. Ho, MD, FACS, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Adverum, Aerie Pharmaceuticals, AGTC, Alcon Vision, Aldeyra, Allergan, Apellis, Asclepix, Beaver-Visitec International, Chengdu Kanghong Biotechnology, Genentech, Regenxbio, Meira GTX Gyroscope, Clearside, Iveric/Ophthotech, Janssen/Johnson&Johnson Vision, Lineage, Notal Vision, Ocular Therapeutixs, ONL, Regeneron Pharmaceuticals. Grant/Research Support: Adverum, Aerie Pharmaceuticals, AGTC, Alcon Vision, Aldeyra, Allergan, Apellis, Asclepix, Chengdu Kanghong Biotechnolog, Genentech, Graybug, Gyroscope, Iveric/Ophthotech, Janssen/Johnson&Johnson Vision, Lineage, Lumithera, Meira G TX , National Eye Institute, Notal Vision, Novartis, ProQR, Regeneron Pharmaceuticals, Inc., and Regenxbio. Other support: Covalent.

      Jennifer I. Lim, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisor: Alcon, Aura, Cognition, Eyenuk, Genentech, Novartis, Opthea, Quark, and Santen. Consultant: Luxa, and Unity. Grant/Research Support: Aldeyra, Chengdu Kanghong, Clearside, Genentech, NGM, Regeneron Pharmaceuticals, and Stealth. Patents/Royalty: CRC Press/Taylor and Francis.

      The Evolve staff and planners have no financial relationships with commercial interests.
      Nisha Mukherjee, MD, peer reviewer, has no financial relationships with commercial interests.

    • Disclaimer

      OFF-LABEL STATEMENT
      This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

      DISCLAIMER
      The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Regeneron Pharmaceuticals.

    • System Requirements

      • Supported Browsers (2 most recent versions):
        • Google Chrome for Windows, Mac OS, iOS, and Android
        • Apple Safari for Mac OS and iOS
        • Mozilla Firefox for Windows, Mac OS, iOS, and Android
        • Microsoft Edge for Windows
      • Recommended Internet Speed: 5Mbps+

    • Publication Dates

      Release Date:

      Expiration Date:

    Ready to Claim Your Credits?

    You have attempts to pass this post-test. Take your time and review carefully before submitting.

    Good luck!

    Register

    We're glad to see you're enjoying Evolve Medical Education…
    but how about a more personalized experience?

    Register for free